Date: 2014-07-24
Type of information: Collaboration agreement
Compound: GENALICE MAP
Company: GENALICE (The Netherlands) deCODE Genetics an Amgen\'s subsidiary (Iceland)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism: GENALICE MAP is a DNA data processing software solution.
Disease:
Details: * On July 24, 2014, GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to include up to 10,000 full human genomes. deCODE Genetics has one of the world’s largest Biobanks and is generating large amounts of full human genome data with its Illumina HiSeq X Ten Next-Generation Sequencing (NGS) machines. GENALICE will install an XL version of its all-in-one bioinformatics appliance, GENALICE VAULT, which is preloaded with MAP, and can process one full human genome every other minute. The project will kick off in August and final results are expected to be ready in December this year.
Financial terms:
Latest news:
